Pak Province may Lift Ban on New Drug Stores and also Revise Licensing Rules to Combat Fake Drugs

Category: Corporate News
Wednesday, July 23, 2008 at 10:30:00 PM
 Font Size 
Sindh, a province of Pakistan, may lift the ban on new drug stores and put in place revised licensing rules to combat fake drugs.

Special secretary of the provincial Health department, Dr Shafqat H. Abbasi, told Dawn newspaper that his department was actively considering withdrawing the ban notification of last year.


Licensing of new medical stores could be resumed, but strictly in line with the guidelines and directives of the Supreme Court, he said.

“In future, new medical stores will be required to furnish documents showing that they employed a bachelor of pharmacy at the store, while the already existing licensed stores will be given a six-month relaxation, as is permissible under the Sindh Drug Rules,” Dr Abbasi said.

In a suo motu action on the spurious drugs business in the country, the Supreme Court had asked the Health ministry to check the prevalence of spurious drugs, ensuring implementation of the drug laws in the provinces besides the presence of a qualifed pharmacist at every drug store.

The court did not ask to stop giving licences, but had directed that new drug sale licences should be issued to those establishments which had registered pharmacists since a sufficient number of graduate pharmacists was available.

The Supreme Court’s guidelines had also called for computerization of all data relating to drug stores or pharmacies both at the provincial level and the federal level in order to ensure that no pharmacist is cited as being in charge of more than one medical store.
Page 1 Page 1 | 2  Next
       Email Email      RSS Feeds RSS Feeds      Print this page Print      Save this page Save      Link Link      Syndicate Syndicate      Comments Comments
  
Comment & Contribute
Be the first to comment
* Your comment can be maximum of 2500 characters
Notify me when reply is posted   

Corporate Related News

.
Johnson & Johnson Inks $1 Billion Alzheimer's Pact With Elan
.
OncoGenex Says Will Amend Prostate Cancer Trial
.
Glenmark Says Phase III Trials of Diabetes Drug Will Start by Year-end
.
GSK Inks Deal With Chinese Biotech To Make Flu Vaccines
Read More

Related Links

500 + Health news categories
Latest Health News From Leading Resources
Updated every 30 minutes
Latest Headlines
WHO Says Access to Swine Flu Vaccine a 'critical Question' (4 hrs ago)
Memory Decline in Alzheimer's Mice Set Right by Human Blood Stem Cell Growth Factor (4 hrs ago)
Scientists Identify Why H1N1 Flu Spreads from Person to Person Less Effectively Than Other Flu Viruses (4 hrs ago)
PET can Measure Effectiveness of Novel Breast Cancer Treatment, Study Says (4 hrs ago)
Supply of Additional Private Services on the Rise (4 hrs ago)
Increased Research Output Seen in Developing Countries (4 hrs ago)
Call for Public Debates on Future Uses of Stem Cells (4 hrs ago)
All Latest News
Popular News Topics
News Archive
Date :
Category :
Keyword :
Medindia Special Reports
interview-Dr-srinivasan.jpg
world-hepatitis-day-2009.jpg
world-no-tobacco-day2009.jpg
sleepcon-featurednews.jpg
parliament.jpg
Web Medindia  Advanced Search
Feedback
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy |  © All Rights Reserved 1997 - 2009